FdaApplication
ANDA 216171
Identifiers
- fda_app_no: ANDA216171
Properties
| Property | Value |
|---|---|
| applicant_name | BE PHARMACEUTICALS AG |
| application_type | ANDA |
| approval_date | 2022-05-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
1 product